Australia markets closed

Humanigen, Inc. (HGENQ)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0002+0.0001 (+100.00%)
At close: 01:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 23.82k
Enterprise value -21.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.01
Price/book (mrq)N/A
Enterprise value/revenue -1.61
Enterprise value/EBITDA 0.05

Trading information

Stock price history

Beta (5Y monthly) -1.22
52-week change 3-99.87%
S&P500 52-week change 326.24%
52-week high 30.2070
52-week low 30.0000
50-day moving average 30.0007
200-day moving average 30.0019

Share statistics

Avg vol (3-month) 334.57k
Avg vol (10-day) 316.17k
Shares outstanding 5119.08M
Implied shares outstanding 6238.16M
Float 8110.49M
% held by insiders 110.35%
% held by institutions 10.41%
Shares short (14 July 2023) 44.14M
Short ratio (14 July 2023) 41.52
Short % of float (14 July 2023) 43.88%
Short % of shares outstanding (14 July 2023) 43.48%
Shares short (prior month 15 June 2023) 43.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Sept 2020
Ex-dividend date 4N/A
Last split factor 21:5
Last split date 314 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,916.29%

Management effectiveness

Return on assets (ttm)-85.05%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.7M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)-78.70%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-53.63M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.1M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.09
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-64.31M
Levered free cash flow (ttm)-45.92M